Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA

Emerging Infectious Diseases

Volumn 17, Issue 3, 2011, Pages 506-509

  Kendall, Brian A ^a   Varley, Cara D ^b   Choi, Dongseok ^b   Maureen Cassidy, P ^c   Hedberg, Katrina ^c   Ware, Mary A ^d   Winthrop, Kevin L ^b  

^a UNIVERSITY OF UTAH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON PUBLIC HEALTH DIVISION   (United States)

^d MULTNOMAH COUNTY HEALTH DEPARTMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AGE DISTRIBUTION; ANOREXIA; ARTICLE; BIRTHPLACE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; ETHNICITY; FEVER; HEMOPTYSIS; HUMAN; LUNG CAVITATION; LUNG INFILTRATE; LUNG TUBERCULOSIS; LYMPHADENOPATHY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NIGHT SWEAT; PREDICTION; RISK FACTOR; SMEAR; TUBERCULOSIS CONTROL; UNITED STATES; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; OREGON; PREDICTIVE VALUE OF TESTS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 79952332494     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1703.101164     Document Type: Article

References (11)

1. Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med. 2007;176:306-13. DOI: 10.1164/ rccm.200702-201OC
2. Cassidy PM, Hedberg K, Saulson A, McNelley E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49:e124-9. DOI: 10.1086/648443
3. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features; an emerging public health disease. Am J Respir Crit Care Med 2010 Oct 1;182(7):977-82. Epub 2010 May 27.
4. BaHammam A, Kambal A, Sharif Y, Masood M, Isnani A, Youssef I, et al. Comparison of clinico-radiological features of patients with positive cultures of nontuberculous mycobacteria and patients with tuberculosis. Saudi Med J. 2005;26:754-8.
5. Laissy JP, Cadi M, Cinqualbre A, Boudiaf ZE, Lariven S, Casalino E, et al. Mycobacterium tuberculosis versus nontuberculous mycobacterial infection of the lung in AIDS patients: CT and HRCT patterns. J Comput Assist Tomogr. 1997;21:312-7. DOI: 10.1097/00004728- 199703000-00029
6. Primack SL, Logan PM, Hartman TE, Lee KS, Muller NL. Pulmonary tuberculosis and Mycobacterium avium-intracellulare: a comparison of CT fi ndings. Radiology. 1995;194:413-7.
7. Portland State University Population Research Center. Annual Oregon population report [cited 2011 Jan 3]. http://www.pdx.edu/prc/annual-oregon-population-report
8. Griffith DE, Aksamit T, Brown-Elliot BA, Catanzara A, Daley C, Gordin F, et al. An offi cial ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. Erratum in: Am J Respir Crit Care Med. 2007 Apr 1;175(7):744-5. DOI: 10.1164/ rccm.200604-571ST
9. Bergstrahl E. The Mayo Clinic Division of Biomedical Statistics and Informatics [cited 2009 Oct 12]. http://mayoresearch.mayo.edu/mayo/research/biostat/sasmacros.cfm
10. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2008.Atlanta: The Centers; 2009. p. 35-47.
11. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax. 2007;62:661-6. DOI: 10.1136/thx.2006.070797